ONC.L Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 17:24):

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally...

Stats
Dzisiejszy wolumen	86 635.00
Średni wolumen	74 365.00
Kapitalizacja rynkowa	17.05M
EPS	£0 ( 2023-09-28 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-1.640
ATR14	£0 (0.00%)

Oncimmune Holdings PLC Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncimmune Holdings PLC Finanse

Annual	2022
Przychody:	£1.15M
Zysk brutto:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Przychody:	£1.15M
Zysk brutto:	£792 000 (68.75 %)
EPS:	£0.0565

FY	2022
Przychody:	£3.86M
Zysk brutto:	£1.46M (37.76 %)
EPS:	£-0.140

FY	2021
Przychody:	£3.72M
Zysk brutto:	£2.86M (76.76 %)
EPS:	£-0.0717

Financial Reports:

No articles found.

Oncimmune Holdings PLC

Oncimmune Holdings plc develops and commercializes technologies that enable cancer diagnosis in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a immunodiagnostic test for detecting and identifying lung cancer. The company also develops SeroTag, a platform that is used to discover and validate biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Nottingham, the United Kingdom.